Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-05-30A Sham-Controlled Pilot Trial of Focused Ultrasound Modulation of the Globus Pallidus Interna in Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-05-30The Feasibility and Efficacy of Baduanjin Exercise on Cognition and Physical Fitness Among Patients With Schizophrenia:Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-05-29A Phase Ⅰ, Randomized, Double-blind, Placebo-controlled, Single Dose Ascending Study to Assess the Safety, Tolerability, and Pharmacokinetics of LPM787000048 Maleate Sustained-release Tablet (LY03020) in Chinese Healthy Adult Subjects
-
CLINICAL_TRIALS study record update · 2025-05-23Ningbo Schizophrenia Cohort, a Longitudinal Population-based Ambispective Cohort Study
-
CLINICAL_TRIALS study record update · 2025-05-23A Multi-center, Randomized, Controlled Trial of Brexpiprazole for the Treatment of Co-occurring Schizophrenia and Substance Use Disorder
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-05-22Examining Neuroplasticity Modulation as Mechanistic Basis of tDCS Treatment Effects on Auditory Verbal Hallucination in Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-05-22iTBS to Enhance Social Cognition in People With Psychosis
-
CLINICAL_TRIALS study record update · 2025-05-20Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-05-18Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)
-
CLINICAL_TRIALS study record update · 2025-05-16A Randomized Controlled Trial of a Ketogenic Metabolic Therapy in Schizophrenia, Bipolar Disorder, Major Depressive Disorder: Deep Omic Profiling
-
CLINICAL_TRIALS study record update · 2025-05-15A Multi-center, Exploratory, Single-Arm, 7-week Study to Evaluate the Feasibility and Acceptability of Treatment With CT-155 in People With Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-05-14Skills for Wellness: Cognitive-behavioural Skills Training for Psychotic-like Experiences, Basic Symptoms, Affective Lability and Anxiety in Youth
-
CLINICAL_TRIALS study record update · 2025-05-14The Effects of Auditory Stimulation During Sleep on Offline Learning and Thalamocortical-hippocampal Connectivity in Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-05-14Interdisciplinary Approach to Maximize Adolescent Potential: Genetic Counselling Interventions to Reduce Negative Environmental Effects
-
CLINICAL_TRIALS study record update · 2025-05-14Profiling Vulnerability and Resilience for Mental Illness Following Viral Infections: Translating Epidemiology to Deep-phenotyping
-
CLINICAL_TRIALS study record update · 2025-05-13Online High-definition Transcranial Direct Current Stimulation Over the Left Dorsolateral Prefrontal Cortex During a Working Memory Task for Treating Negative Symptoms of Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-05-11Low-dose Buprenorphine as a Modulator of Social Motivation in Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-05-07Effects of Psyllium on Constipation in Schizophrenic: A Randomized Controlled Crossover Trial
-
CLINICAL_TRIALS study record update · 2025-05-04A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Electrophysiology of ANAVEX3-71 in Adult Patients With Schizophrenia in a Multiple Ascending Dose Study (Part A), Followed by a Double-Blind, Randomized, Placebo-Controlled Study (Part B)
-
CLINICAL_TRIALS study record update · 2025-05-01A Multicenter, Exploratory, Randomized, Double-Arm, 4-week Study to Evaluate the Overall Effects of Treatment With Abbreviated CT-156 in People With Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-04-27A 52-Week, Open-Label, Prospective, Multicenter, International Study of a Transition to the Paliperidone Palmitate 3-Month Formulation In Patients With Schizophrenia Previously Stabilized on the Paliperidone Palmitate 1-Month Formulation
-
CLINICAL_TRIALS study record update · 2025-04-27An Open-label Prospective Trial to Explore the Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Subjects With Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-04-27A Pilot-Study in Rwandan Health Care Settings to Examine the Feasibility of a Large Pragmatic Clinical Study to Assess the Value of Paliperidone Palmitate in Rwanda
-
CLINICAL_TRIALS study record update · 2025-04-27Cross-sectional Survey to Collect Treatment Experience Feedback From Patients, Physicians, Nurses and Carers After Switching to Paliperidone Palmitate 3-monthly
-
CLINICAL_TRIALS study record update · 2025-04-27A Prospective, Open Label, Quasi-Experimental Study of Adult Patients With Schizophrenia or Schizoaffective Disorder Within Five Years of Diagnosis Who Will Receive SEEC Intervention